Skip to main content

Ana Ferrigno, MD

Ana Ferrigno, MD
Conference Coverage
12/28/2023
Ana Ferrigno, MD, discussed results from an international cohort study which demonstrated that the use of taxane-containing chemotherapy during pregnancy does not increase the risk of obstetric and neonatal complications.
Ana Ferrigno, MD, discussed results from an international cohort study which demonstrated that the use of taxane-containing chemotherapy during pregnancy does not increase the risk of obstetric and neonatal complications.
Ana Ferrigno, MD, discussed...
12/28/2023
Oncology